» Articles » PMID: 31665268

Combinations of Cardiac and Non-cardiac Predictors for Prognoses in Patients with Acute Heart Failure

Overview
Date 2019 Oct 31
PMID 31665268
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: In contemporary heart failure (HF) practice, prognostic value for combinations of cardiac and non-cardiac predictors remains poorly understood. We analysed the combinatorial predictors of outcomes in acute HF patients.

Methods And Results: This longitudinal cohort study included consecutive patients admitted for acute decompensated HF between April 2015 and March 2018 in an urban hospital. The main outcomes are HF readmission within 6 months after discharge or all-cause death. A total of 451 patients with 662 admissions were enrolled and the data including frailty and echocardiographic parameters were analysed by multivariate and matched cohort analyses. The mean age of the patients was 76.8 years. We constructed a multi-frailty index (MFI) ranging from 0 to 3 points as a composite of non-cardiac comorbidities and biopsychosocial frailty. In matched cohort of patients with ejection fraction ≧50% (HFpEF), MFI ≧1, pulmonary hypertension (PH; peak flow velocity of tricuspid regurgitation ≧2.9 m/s by echocardiography), and pancytopenia at discharge were strong predictors of HF readmission [odds ratios (ORs), 4.33, 2.5, and 2.86; P = 0.02, 0.05, and 0.02, respectively], and MFI ≧2 was the only predictor for all-cause death. For ejection fraction <40%, age, BNP ≧800 pg/mL, increase in estimated glomerular filtration rate during hospitalization, and lymphocytopenia plus anaemia predicted HF readmission (ORs, 1.77, 2.72, 0.73, and 2.89; P = 0.001, 0.05, 0.04, and 0.03, respectively). In contrast, diabetes mellitus was the only specific predictor found in patients over 80 years old.

Conclusion: These data identified multi-frailty and PH or mild pancytopenia as synergistic predictors of HF readmission in HFpEF patients.

Citing Articles

Causal relation of tricuspid regurgitation for heart failure outcomes: a mediation analysis of echocardiographic predictors.

Hakuno D, Fukae T, Takahashi M, Sueyoshi K Eur Heart J Open. 2022; 1(2):oeab027.

PMID: 35919266 PMC: 9241574. DOI: 10.1093/ehjopen/oeab027.


Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.

Mone P, Lombardi A, Gambardella J, Pansini A, Macina G, Morgante M Diabetes Care. 2022; 45(5):1247-1251.

PMID: 35287171 PMC: 9174954. DOI: 10.2337/dc21-2434.


Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.

Lebedev D, Lyasnikova E, Vasilyeva E, Babenko A, Shlyakhto E J Diabetes Res. 2020; 2020:6976153.

PMID: 33224989 PMC: 7669344. DOI: 10.1155/2020/6976153.


Plasma HbA1c in the investigation of suspected heart failure in general practice: An audit of the 2018 NICE guidelines update.

Paschalis T, Jones C J Family Med Prim Care. 2020; 9(2):1098-1102.

PMID: 32318474 PMC: 7114051. DOI: 10.4103/jfmpc.jfmpc_917_19.